Please select the option that best describes you:

What is your neoadjuvant chemotherapy of choice in patients with ER+ breast CA who are receiving neoadjuvant therapy with goal to convert to BCS from mastectomy?  

Would your decision for anthracycline change if the patient were elderly?



Answer from: Medical Oncologist at Academic Institution
Sign in or Register to read more